BioSpace News Archive

BioMidwest

Tempus Introduces xM to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only

Tempus, a leader in artificial intelligence and precision medicine, announced the addition of a novel MRD assay, xM, to its comprehensive testing solutions.

January 18, 2024
·
3 min read
Policy

argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis

argenx SE announced that Japan’s Ministry of Health, Labour and Welfare approved VYVDURA® injection for subcutaneous use for the treatment of adult patients with generalized myasthenia gravis, who do not have sufficient response to steroids or non-steroidal immunosuppressive therapies.

January 18, 2024
·
3 min read
Drug Development

Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck

Oxford BioTherapeutics announces that the first patient has been dosed in a Phase 1b trial investigating OBT’s lead candidate, OBT076, in patients with Adenoid Cystic Carcinoma of the head and neck.

January 18, 2024
·
5 min read
Policy

NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD

NeuroSigma announced that the U.S. Food and Drug Administration cleared use of NeuroSigma’s second-generation Monarch eTNS System for treating pediatric attention deficit hyperactivity disorder.

January 18, 2024
·
2 min read
Drug Development

PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

PeproMene Bio, Inc. announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia clinical trial of PMB-CT01 has reached complete remission at one-month post treatment.

January 18, 2024
·
4 min read
BioForest

Simulab Corporation Announces New Technology in Medical Simulation With SimuSkin(TM)

Simulab Corporation proudly unveils its latest technology - SimuSkin.

January 18, 2024
·
2 min read
Business

CENTOGENE Announces Preliminary Full Year 2023 Revenue

Centogene N.V. today announced preliminary unaudited revenue for full year 2023 between approximately €48.5 million and €49.0 million, reflecting a growth rate over 2022 in the mid-single digits.

January 18, 2024
·
6 min read
Genetown

SmartLabs Announces $48 Million Series C Funding to Advance Its Laboratory Infrastructure and Resourcing Solutions

SmartLabs , the leading provider of flexible laboratory infrastructure and resourcing solutions, today announced the raise of a $48 million Series C financing.

January 18, 2024
·
3 min read
Business

Orthofix Announces Commercial Partnership with MRIguidance

Orthofix Medical Inc today announced it has entered into an agreement with MRIguidance to distribute its BoneMRI™ imaging software in the U.S.

January 18, 2024
·
5 min read
Business

Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer

Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.

January 18, 2024
·
2 min read